Exploring the Mysteries of the Human Brain Adds a New Model: Chinese Scientists Successfully Create Spinal Trigeminal
Release time:
2024-10-21
Nucleus Organoids Neuroscience, a brilliant gem in the life sciences, is leading us to delve into the mysteries of the human brain, paving new paths for treating brain diseases and advancing artificial intelligence. In the past, scientists mainly relied on model animals and two-dimensional cell cultures to unveil the secrets of the brain. However, the advent of brain organoids is like a beacon illuminating the journey of exploration.
According to the latest report by China News Service, Xiang Yangfei's research team from the School of Life Science and Technology at ShanghaiTech University has announced a groundbreaking success in constructing human brain organoids specific to the spinal trigeminal nucleus (SpV) and building an in vitro model of inter-brain connection associated with it. This innovation is not only the first of its kind in China but also provides a new perspective and tool for global brain science research.
The SpV, a "giant" cranial nerve nucleus located in the medulla, plays a critical role in receiving sensory information from the craniofacial region and transmitting it to the thalamus. Despite its close connection to normal physiological functions and multiple pathological mechanisms in the human body, there has been a lack of human-derived research models targeting the SpV until now. Xiang Yangfei's team successfully simulated the characteristics and functions of the SpV by finely regulating the three-dimensional neural differentiation of human pluripotent stem cells in vitro.
During the long-term cultivation process, researchers were pleasantly surprised to find that SpV neurons spontaneously formed axonal bundle structures in the organoids, suggesting their potential projection abilities. This discovery undoubtedly provides valuable model resources for studying the development of human brain nuclei, neural targeting projection, and related pathological mechanisms.
Brain organoids, the "mini-brains," have demonstrated their unique value in various fields such as brain development, hereditary brain diseases, neurodegenerative diseases, brain evolution, regenerative medicine, brain tumors, and pathogen infections. Although they cannot completely replace the real human brain, significant strides have been made in recreating the intricate structure and developmental process of brain tissues in vivo.
Xiang Yangfei emphasized that every technological advance is a brave exploration of the unknown. The SpV-specific human brain organoids they constructed represent another solid step toward uncovering the mysteries of the human brain. With the continuous development and improvement of technology, it is believed that we can gain a deeper understanding of the human brain, contributing more wisdom and strength to human health and well-being in the future.
Previous article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
